Osphena

Short answer: start by asking a clinician for evidence‑based, FDA‑approved hormone therapy that fits your symptoms and risk profile (for most people this is estradiol plus appropriate progestogen if you have a uterus). Consider compounded “bioidentical” HRT only if a commercial product doesn’t meet your needs — and if you do, use an experienced menopause clinician and a PCAB‑accredited compounding pharmacy. Why — quick comparison Traditional (FDA‑approved) HRT: known doses/quality, studied in large trials, predictable risks and benefits. Common, effective options include bioidentical molecules (estradiol, micronized progesterone) and non‑bioidentical ones (conjugated equine estrogens, medroxyprogesterone). Compounded BHRT: often marketed as more “natural” or tailored, but it lacks large randomized‑trial data, has variable dosing/quality, and compounded products are not FDA‑approved. If the molecule and dose are the same as an approved product, risks are similar. What to specifically ask for (phrased to take to your clinician) If you want transdermal estradiol (lower VTE risk, good for vasomotor symptoms): ask about estradiol patches such as Vivelle‑Dot or Climara. If you prefer oral estradiol: ask about Estrace (estradiol) tablets. For progesterone to protect the endometrium (if you have a uterus): ask about micronized progesterone (Prometrium) or consider a levonorgestrel IUD (Mirena) as an alternative. For vaginal dryness/local symptoms: ask about Vagifem (vaginal estradiol tablets), estradiol cream, or nonhormonal options; for moderate dyspareunia consider Intrarosa (prasterone) or Osphena (ospemifene) as applicable. If you’re considering systemic testosterone (less commonly used): note there is no widely approved female testosterone product in the U.S.; this is off‑label and should be managed by a specialist. Where to go / who to see Start with: your gynecologist or primary care clinician who is comfortable with menopause management. For specialized care: look for a North American Menopause Society (NAMS)‑certified menopause practitioner, an endocrinologist with menopause experience, or a reputable menopause clinic (examples: Mayo Clinic Menopause Clinic, Cleveland Clinic Menopause Center) — they focus on up‑to‑date, evidence‑based HRT. If you’re given a compounded BHRT prescription: fill it at a PCAB‑accredited compounding pharmacy (search PCAB’s directory). Using an accredited pharmacy reduces some quality risk compared with unaccredited compounding shops. Practical next steps for your visit Bring your medical history (age, smoking, blood pressure, family history of breast/CVD, prior breast biopsies, current meds). Ask your clinician to explain risks/benefits for your age and time since menopause (HRT tends to have a more favorable balance when started <10 years from menopause or under age ~60). Ask whether a transdermal route (patch/gel) is preferable for you. If you’re considering BHRT, ask why an FDA‑approved product won’t work, what evidence supports the compounded formulation, and which compounding pharmacy they recommend (verify PCAB accreditation). If you need help finding a specialist, use the NAMS “find a menopause practitioner” tool or get a referral to a major center (Mayo, Cleveland, etc.). If you want, tell me your age, symptoms, and any major medical history (smoking, clotting disorder, breast cancer, heart disease) and I’ll give a more personalized suggestion of what to ask for.

Mentioned in position 8 of 11

Short answer: Often no — it’s not automatically “too late” to start hormone therapy in your late 50s, but whether it’s a good idea depends on what symptoms you want treated, how long it’s been since menopause, and your medical history. I have a few quick clarifying questions before more specific guidance: are you asking about menopausal HRT (estrogen ± progestogen) or gender‑affirming HRT? Do you still have a uterus? Any history of breast cancer, blood clots, stroke, liver disease, or uncontrolled high blood pressure? What you should know now (overview) Benefits: Systemic HRT (estrogen ± progestogen) is effective for hot flashes, night sweats, sleep and mood symptoms, and can help prevent bone loss. Local (vaginal) estrogen is very effective for genitourinary symptoms (dryness, painful sex) at low doses with minimal systemic absorption. Timing and risks: Starting systemic HRT within about 10 years of menopause or under about age 60 is generally considered to have a more favorable benefit–risk profile. Starting later (for example well into the 60s) can raise certain risks (blood clots, stroke, and possibly some differences in cardiovascular outcomes), so decisions are more individualized. Contraindications: Active or recent breast or endometrial cancer, active or recent venous thromboembolism (VTE), uncontrolled stroke or heart disease, and unexplained vaginal bleeding are important reasons to avoid or delay systemic HRT. Vaginal estrogen often remains an option even when systemic HRT is contraindicated. Practical options and brand examples Transdermal estradiol (patch): Vivelle‑Dot, Climara, Alora — transdermal patches have a lower risk of blood clots compared with oral estrogen and are a good option for many older people. Oral estradiol: Estrace (micronized estradiol) — effective but oral estrogen has a higher VTE risk than transdermal. Vaginal/local estrogen for GSM (genitourinary syndrome of menopause): Vagifem (vaginal tablet), Estring (vaginal ring), and low‑dose estradiol creams — very useful for vaginal dryness, painful sex, and recurrent urinary symptoms and often safe even if systemic HRT isn’t recommended. Progesterone (if you have a uterus): Prometrium (micronized progesterone) — given with estrogen to protect the lining of the uterus; some clinicians prefer natural micronized progesterone over some synthetic progestins for a possibly better side‑effect profile. Non‑hormonal alternatives for hot flashes: low‑dose SSRI/SNRI (e.g., venlafaxine by prescription), gabapentin; for vaginal dryness, moisturizers and lubricants or ospemifene (Osphena) as a non‑estrogen oral option. Bone protection alternatives: If HRT isn’t suitable for osteoporosis prevention, consider alendronate (Fosamax) or denosumab (Prolia) — discuss with your doctor. Where to get care See your primary care clinician or a gynecologist/menopause clinic for individualized assessment (medical history, risks, baseline mammogram as appropriate, BP, labs). If your question is about gender‑affirming HRT, seek a gender clinic or specialized telehealth service (examples: Fenway Health, Planned Parenthood with trans care, or telehealth providers such as Folx or Plume) for protocols and monitoring. Next steps I recommend Tell me whether this is for menopausal symptoms or gender‑affirming care and a little about your medical history (uterus status, any clot/cancer/heart disease history). I can give more tailored information. Make an appointment with a clinician to review risks and do baseline screening (mammogram if due, BP, review of clot risk). If starting HRT, ask about transdermal estradiol if you have clot risk factors, and about micronized progesterone if you have a uterus. Ask about low‑dose vaginal estrogen if genitourinary symptoms are your main concern. If you want, tell me more about your symptoms and health history and I’ll help you draft questions to bring to your clinician.

Mentioned in position 8 of 14